Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis.
- DOI
- 10.1007/s10238-025-01738-4
- Published
- 2025 Jun 25
- Container
- Clinical and experimental medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10238-025-01738-4,
title = {Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis.},
author = {Isufi D and Schwarz CW and Jensen MB and Seidelin J and Skov L and Loft N},
year = {2025},
journal = {Clinical and experimental medicine},
doi = {10.1007/s10238-025-01738-4},
url = {https://doi.org/10.1007/s10238-025-01738-4}
}RIS
TY - JOUR TI - Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis. AU - Isufi D AU - Schwarz CW AU - Jensen MB AU - Seidelin J AU - Skov L AU - Loft N PY - 2025 JO - Clinical and experimental medicine DO - 10.1007/s10238-025-01738-4 UR - https://doi.org/10.1007/s10238-025-01738-4 ER -
APA
D, I., CW, S., MB, J., J, S., L, S., & N, L. (2025). Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis.. Clinical and experimental medicine. https://doi.org/10.1007/s10238-025-01738-4
Source records
- pubmed · retrieved 2026-09-25T06:47:13.747Z
- europe-pmc · retrieved 2026-09-25T06:47:13.745Z